Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

Market Cap	149.14B -35.4%
Revenue (ttm)	275.51B +1.3%
Net Income	19.98B +88.2%
EPS	1,134.13 +97.8%
Shares Out	17.92M
PE Ratio	7.34
Forward PE	n/a
Dividend	155.00 (1.86%)
Ex-Dividend Date	Dec 29, 2025

Volume	42,886
Open	8,320.00
Previous Close	8,320.00
Day's Range	8,150.00 - 8,490.00
52-Week Range	8,100.00 - 16,240.00
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	May 27, 2026

About KRX:007570

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1946
• Employees: 666
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 007570

Financial Performance

In 2025, KRX:007570's revenue was 272.42 billion, an increase of 1.39% compared to the previous year's 268.68 billion. Earnings were 6.73 billion, a decrease of -25.52%.